医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.

广告
第一作者: Juan,Carrillo-Reixach
第一单位: Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain.
作者单位: Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain. [1] Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Translational research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. [2] Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain. [3] Translational research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, USA. [4] CIBER, Hepatic and Digestive Diseases, Barcelona, Spain; Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain; Gastroenterology Department, Hospital Universitari Josep Trueta, Girona, Spain. [5] MARGenomics, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. [6] PMPPC, IGTP, Badalona, Spain. [7] XenTech, Evry, France; Instituto di Ricerca Pediatrica, Corso Stati Uniti 4, Padova, Italy. [8] Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute, L'Hospitalet del Llobregat, Barcelona, Spain. [9] Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, Lindwurmstr. 2a, 80337 Munich, Germany. [10] Hospital Vall d'Hebron, Pathology Department, Barcelona, Spain. [11] University Hospital La Paz, Pathology Department, Madrid, Spain. [12] Hospital Vall d'Hebron, Pediatric Oncology Department, Barcelona, Spain. [13] Hospital Vall d'Hebron, Pediatric Surgery Department, Barcelona, Spain. [14] MDS Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. [15] High Content Genomics and Bioinformatics Unit, PMPPC, IGTP, Badalona, Spain. [16] Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. [17] Pediatric Oncology Unit, Department of Pediatrics, University Hospital Reina Sofía, Córdoba, Spain. [18] University Hospital Universitario Virgen del Rocío, Pediatric Oncology Department, Sevilla, Spain. [19] University Hospital La Paz, Pediatric Surgery Department, Madrid, Spain. [20] University Hospital La Paz, Pediatric Oncology Department, Madrid, Spain. [21] Biomedical Research in Cancer Stem Cells Group, Pathology Department, Institut de Recerca Hospital Vall d'Hebron (VHIR), Barcelona, Spain. [22] Department of Pediatric Oncology, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland. [23] Bicêtre Hospital, Le Kremlin-Bicêtre, France. [24] Pediatric Oncology, Hospital Universitario Donostia, Doctor Begiristain Kalea, 117, 20080, Donostia, Spain. [25] Department of Pediatric Hematology and Oncology, HM Montepríncipe Hospital, Boadilla del Monte, Madrid, Spain. [26] Pediatric Oncology and Hematology, Hospital Universitario Cruces, Bilbao, Spain. [27] Division of Hematology-Oncology, Department of Pediatrics, Hospital Universitari Son Espases, Palma de Mallorca, Spain. [28] Medical Oncology Department, Pediatric Oncology Department, University Hospital La Fe, Valencia, Spain. [29] Department of Pathology, Hôpital Universitaire Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, and Université Paris Descartes, Paris, France. [30] IrsiCaixa AIDS Research Institute, IGTP, Badalona, Catalonia, Spain; University of Vic - Central University of Catalonia, Vic, Spain. [31] Stem Cell Transplant Unit, Hospital Luis Calvo Mackenna, Santiago, Chile. [32] Department of Pediatric Oncology, Childrens University Hospital Brno, Brno, Czech. [33] Department of Pediatric Hematology, Oncology and Hematopoietic Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium. [34] Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain. [35] Oncohematology Service, Hospital Gregorio Marañón, Madrid, Spain. [36] CIBER, Hepatic and Digestive Diseases, Barcelona, Spain; Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain. [37] PMPPC, IGTP, Badalona, Spain; Consortium for the Study of Thyroid Cancer, CECaT, Barcelona, Spain. [38] Department of Surgery and Urology for Children and Adolescents, Medical University of Gdansk, Gdansk, Poland. [39] Department of Oncology, Birmingham Women's and Children's Hospital, Birmingham, UK. [40] Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, USA; Graduate School of Biomedical Sciences, One Gustave L. Levy Place, Box 1022, New York, NY; Tisch Cancer Institute, Cancer Immunology Program, Icahn School of Medicine at Mount Sinai, New York, NY; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY. [41] INSERM, UMR 1193, Paul-Brousse Hospital, Hepatobiliary Centre, Villejuif, France. [42] CIBER, Hepatic and Digestive Diseases, Barcelona, Spain; Innate Immunity Group, IGTP, Badalona, Spain. [43] Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Translational research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. [44] Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain. Electronic address: carmengol@igtp.cat. [45]
DOI 10.1016/j.jhep.2020.03.025
PMID 32240714
发布时间 2025-09-23
提交
  • 浏览4
Journal of hepatology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷